Strand Therapeutics
Cambridge
About Strand Therapeutics
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $257.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: strandtx.com
- Phone: +1 (309) 360-9875
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/strand-therapeutics-123201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.